Company performance
Add to research
Current Price
as of Jun 13, 2025$4.39
P/E Ratio
N/A
Market Cap
$37.93M
Description
Add to research
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.
Metrics
Add to research
Overview
- HQNewton, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerKPTI
- Price$4.39+0.69%
Trading Information
- Market cap$37.93M
- Float92.16%
- Average Daily Volume (1m)79,210
- Average Daily Volume (3m)112,379
- EPS-$7.34
Company
- Revenue$142.13M
- Rev growth (1yr)-9.39%
- Net income-$23.46M
- Gross margin95.41%
- EBITDA margin-110.54%
- EBITDA-$33.18M
- EV$148.44M
- EV/Revenue1.04
- P/EN/A
- P/S0.26
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account